You're reading the free version. Trader adds the live tape and alerts.
Start tracking
XENE Sale Disclosure
Cannon Gillian · SEC Form 4 · Filed Jun 8, 2026
Sale
Calculated transaction value
$63.24K
Cannon Gillian Director
XENE
Transaction date
Jun 5, 2026
Public filing date
Jun 8, 2026
Filing lag
Filed 3 days later
XENE daily price context
Close on/before transaction
$51.73
Jun 5, 2026
First close after public filing
$52.79
Jun 9, 2026
30-day return after filing
+32.51%
Through Jul 8, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 1,190 shares @ $53.14
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-262671
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$63.24K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Xenon Pharmaceuticals Inc. XENE Current | Sale | Jun 5, 2026 | $63.24K |